Brian Manby joined WisdomTree in October 2018 as an Investment Strategy Analyst. He is responsible for assisting in the creation and analysis of WisdomTree’s model portfolios, as well as helping support the firm’s research efforts. Prior to joining WisdomTree, he worked for FactSet Research Systems, Inc. as a Senior Consultant, where he assisted clients in the creation, maintenance and support of FactSet products in the investment management workflow. Brian received a B.A. as a dual major in Economics and Political Science from the University of Connecticut in 2016, and is pursuing the Chartered Financial Analyst designation.
We believe 2021 may mark a turning point for international equity markets. Brian Manby explains why investors should consider focusing on the quality factor when investing abroad.
We believe there is a unique opportunity today to ride the economic recovery in Europe that has yet to find its footing. Brian Manby explains why investors seeking to access European economic recovery should consider our Europe SmallCap Dividend Fund (DFE).
For many, emerging markets (EM) have become synonymous with China, but we believe there is another player worthy of attention in the EM space. Brian Manby makes the case for allocating toward India in 2021.
In today’s market, we believe it is paramount to defend against exorbitant valuations and segments that bleed upward along the size spectrum, all while preserving profitability. Fortunately, the WisdomTree U.S. MidCap Fund can do all three, and it has a 14-year history to prove it. Brian Manby discusses.
We believe in the benefits of a long-term allocation to small caps, but what you own is more important than just owning an allocation. Brian Manby provides a solution for investors looking to allocate to small cap without paying astronomical valuations or sacrificing the quality of underlying company exposures.
